Macquarie Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-636
| Closed | -$40K | – | 1949 |
|
|
2022
Q3 | $40K | Sell |
636
-1,155
| -64% | -$72.6K | ﹤0.01% | 1999 |
|
|
2022
Q2 | $44K | Hold |
1,791
| – | – | ﹤0.01% | 2084 |
|
|
2022
Q1 | $69 | Sell |
1,791
-28,392
| -94% | -$1.09K | ﹤0.01% | 2038 |
|
|
2021
Q4 | $1.77M | Buy |
30,183
+737
| +3% | +$43.1K | ﹤0.01% | 1411 |
|
|
2021
Q3 | $1.75M | Sell |
29,446
-33,461
| -53% | -$1.98M | ﹤0.01% | 1419 |
|
|
2021
Q2 | $5.46M | Sell |
62,907
-919
| -1% | -$79.8K | ﹤0.01% | 1115 |
|
|
2021
Q1 | $5.26M | Sell |
63,826
-11,263
| -15% | -$929K | 0.01% | 895 |
|
|
2020
Q4 | $6.83M | Buy |
75,089
+6,376
| +9% | +$580K | 0.01% | 806 |
|
|
2020
Q3 | $2.75M | Sell |
68,713
-2,063
| -3% | -$82.5K | ﹤0.01% | 957 |
|
|
2020
Q2 | $2.43M | Buy |
+70,776
| New | +$2.43M | ﹤0.01% | 956 |
|
|
2019
Q1 | – | Sell |
-700
| Closed | -$9K | – | 1777 |
|
|
2018
Q4 | $9K | Sell |
700
-200
| -22% | -$2.57K | ﹤0.01% | 1940 |
|
|
2018
Q3 | $15K | Sell |
900
-2,400
| -73% | -$40K | ﹤0.01% | 1943 |
|
|
2018
Q2 | $37K | Buy |
+3,300
| New | +$37K | ﹤0.01% | 1991 |
|
|
2018
Q1 | – | Sell |
-1,800
| Closed | -$11K | – | 2230 |
|
|
2017
Q4 | $11K | Buy |
+1,800
| New | +$11K | ﹤0.01% | 2249 |
|